---
title: "Shingrix (Zoster Vaccine Recombinant, Adjuvanted), all indications: Safety questions"
description: "Safety questions on Shingrix (Zoster Vaccine Recombinant, Adjuvanted) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Side effects and Warnings. Questions: How long do Shingrix side effects last? Can Shingrix cause fainting (syncope)? Who should not get Shingrix (contraindications)? Shingrix and allergic reactions: what precautions apply? 4 further questions follow. 8 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/shingrix/safety"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Shingrix (Zoster Vaccine Recombinant, Adjuvanted), all indications: Safety questions

Manufacturer: GlaxoSmithKline Biologicals; GlaxoSmithKline  
Prescribing information: [Shingrix](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF)  
Indication pages: [Herpes zoster prevention](https://www.evicenter.com/medical-information/shingrix--herpes-zoster-prevention)

## Side effects

<a id="shingrix-side-effects-duration"></a>

### How long do Shingrix side effects last?

> “The local and general adverse reactions seen with SHINGRIX had a median duration of 2 to 3 days.”

Source: [SHINGRIX: Prescribing information, page 6, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=6)

> “The local and 
> general adverse reactions seen with SHINGRIX had a median duration of 1 to 3 days across all studies enrolling 
> immunocompromised subjects.”

Source: [SHINGRIX: Prescribing information, page 11, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=11)

Note: The first passage concerns adults 50 and older in ZOE-50 and ZOE-70; the second concerns the 6 studies in immunocompromised adults 18 and older.

<a id="shingrix-postmarketing-side-effects"></a>

### What Shingrix side effects have been reported since approval?

> “The following adverse reactions have been identified during postapproval use of SHINGRIX. Because these 
> reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably 
> estimate their frequency or establish a causal relationship to the vaccine. 
> General Disorders and Administration Site Conditions 
> Decreased mobility of the injected arm which may persist for 1 or more weeks, injection site induration. 
> Immune System Disorders 
> Hypersensitivity reactions, including angioedema, rash, and urticaria. 
> Nervous System Disorders 
> Guillain-Barré syndrome.”

Source: [SHINGRIX: Prescribing information, page 13, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=13)

## Warnings

<a id="shingrix-fainting"></a>

### Can Shingrix cause fainting (syncope)?

> “Syncope (fainting) can be associated with the administration of injectable vaccines, including SHINGRIX. 
> Syncope can be accompanied by transient neurological signs such as visual disturbance, paresthesia, and 
> tonic-clonic limb movements. Procedures should be in place to avoid falling injury and to restore cerebral 
> perfusion following syncope.”

Source: [SHINGRIX: Prescribing information, page 4, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=4)

<a id="shingrix-contraindications"></a>

### Who should not get Shingrix (contraindications)?

> “Do not administer SHINGRIX to anyone with a history of a severe allergic reaction (e.g., anaphylaxis) to any 
> component of the vaccine or after a previous dose of SHINGRIX [see Description (11)].”

Source: [SHINGRIX: Prescribing information, page 4, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=4)

<a id="shingrix-allergic-reactions"></a>

### Shingrix and allergic reactions: what precautions apply?

> “Prior to administration, the healthcare provider should review the immunization history for possible vaccine 
> sensitivity and previous vaccination-related adverse reactions. Appropriate medical treatment and supervision 
> must be available to manage possible anaphylactic reactions following administration of SHINGRIX.”

Source: [SHINGRIX: Prescribing information, page 4, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=4)

> “Immune System Disorders 
> Hypersensitivity reactions, including angioedema, rash, and urticaria.”

Source: [SHINGRIX: Prescribing information, page 13, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=13)

## Safety

<a id="shingrix-protection-not-guaranteed"></a>

### Does Shingrix protect everyone who receives it?

> “Vaccination with SHINGRIX may not result in protection of all vaccine recipients”

Source: [SHINGRIX: Safety Profile, captured 2026-11-14](https://shingrixhcp.com/home-ic/efficacy-safety/adverse-reactions/#:~:text=Vaccination%20with%20SHINGRIX%20may%20not%20result%20in%20protection%20of%20all%20vaccine%20recipients)

<a id="shingrix-report-side-effects"></a>

### Shingrix side effect: how do I report one?

> “To report SUSPECTED ADVERSE REACTIONS, contact 
> GlaxoSmithKline at 1-888-825-5249 or VAERS at 1-800-822-7967 or 
> www.vaers.hhs.gov.”

Source: [SHINGRIX: Prescribing information, page 1, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=1)

<a id="shingrix-fertility"></a>

### Does Shingrix affect fertility?

> “SHINGRIX has not been evaluated for its carcinogenic or mutagenic potential. Vaccination of female rats with 
> SHINGRIX had no effect on fertility [see Use in Specific Populations (8.1)]. In a male fertility study, rats were 
> vaccinated with 0.1 mL of SHINGRIX (a single human dose is 0.5 mL) on 42, 28, and 14 days prior to mating. 
> There were no effects on male fertility.”

Source: [SHINGRIX: Prescribing information, page 16, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=16)

## Related pages
- [Medical information: Shingrix (Zoster Vaccine Recombinant, Adjuvanted): All indications](https://www.evicenter.com/medical-information/shingrix)
- [Indication](https://www.evicenter.com/medical-information/shingrix/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/shingrix/pharmacology)
- [Specific populations](https://www.evicenter.com/medical-information/shingrix/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/shingrix/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/shingrix/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/shingrix/access-and-coverage)
- [Guidelines](https://www.evicenter.com/medical-information/shingrix/guidelines)
